This page is part of the Making EHR Data MOre available for Research and Public Health (MedMorph) Central Cancer Registry Reporting Content IG (v1.0.0: STU1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
: Cancer Related Medication Administration - Example - TTL Representation
Raw ttl | Download
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:MedicationAdministration ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "cancer-related-medication-administration-example"] ; #
fhir:meta [
( fhir:profile [
fhir:v "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Narrative</b></p><p><b>status:</b> completed</p><p><b>category:</b> Outpatient</p><p><b>medication:</b> rxnorm 1790099 doxorubicin hydrochloride 20 MG per 10 ML Injection</p><p><b>subject:</b> Amy Shaw</p><p><b>effective:</b> 2018-04-22</p><p><b>Performer:</b> Joseph Nichols</p><p><b>reasonReference:</b> Condition-primary-cancer-condition-breast</p><p><b>authoredOn:</b> 2018-04-12</p><p><b>note:</b> doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects.</p><p><b>Route:</b> SNOMED 47625008 Intravenous route (qualifier value)</p><p><b>Dose:</b> 105.96 mg</p></div>"
] ; #
fhir:status [ fhir:v "completed"] ; #
fhir:category [
( fhir:coding [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/medication-admin-category"^^xsd:anyURI ] ;
fhir:code [ fhir:v "outpatient" ] ] )
] ; #
fhir:medication [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [ fhir:v "http://www.nlm.nih.gov/research/umls/rxnorm"^^xsd:anyURI ] ;
fhir:code [ fhir:v "1790099" ] ;
fhir:display [ fhir:v "10 ML doxorubicin hydrochloride 2 MG/ML Injection" ] ] )
] ; #
fhir:subject [
fhir:reference [ fhir:v "Patient/example" ]
] ; #
fhir:effective [ fhir:v "2018-04-22"^^xsd:date] ; #
fhir:performer ( [
fhir:actor [
fhir:reference [ fhir:v "Practitioner/1" ] ]
] ) ; #
fhir:reasonReference ( [
fhir:reference [ fhir:v "Condition/primary-cancer-condition-breast" ]
] ) ; #
fhir:note ( [
fhir:author [
a fhir:Reference ;
fhir:reference [ fhir:v "Practitioner/1" ] ] ;
fhir:time [ fhir:v "2018-04-22"^^xsd:date ] ;
fhir:text [ fhir:v "doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects." ]
] ) ; #
fhir:dosage [
fhir:route [
( fhir:coding [
a sct:47625008 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "47625008" ] ;
fhir:display [ fhir:v "Intravenous route (qualifier value)" ] ] ) ] ;
fhir:dose [
fhir:value [ fhir:v "105.96"^^xsd:decimal ] ;
fhir:unit [ fhir:v "mg" ] ;
fhir:system [ fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ] ;
fhir:code [ fhir:v "mg" ] ]
] . #
|
Propose a change